Article Publish Status: FREE
Abstract Title:

Effect of vitamin K2 on progression of atherosclerosis and vascular calcification in non-dialyzed patients with chronic kidney disease stage 3-5.

Abstract Source:

Pol Arch Med Wewn. 2015 Jul 15. Epub 2015 Jul 15. PMID: 26176325

Abstract Author(s):

Ilona Kurnatowska, Piotr Grzelak, Anna Masajtis-Zagajewska, Magdalena Kaczmarska, Ludomir Stefańczyk, Cees Vermeer, Katarzyna Maresz, Michał Nowicki

Article Affiliation:

Ilona Kurnatowska


Introduction Observational studies have shown that high dietary vitamin K2 intake is associated with reduced risk of coronary vascular disease and vascular calcification. Objectives This prospective randomized intervention study assesses the impact of vitamin K2 substitution on the progression of atherosclerosis and calcification markers in non-dialyzed 3-5 stage CKD patients.  Patients and methods The following measurements were taken at baseline and after 270±12 days ofsupplementation 90 μg vitamin K2 (menaquinone, MK-7) with 10 μg cholecalciferol (K+D group) or 10 μg cholecalciferol (group D) in 42 non-dialyzed CKD patients: Common Carotid Intima Media Thickness (CCA-IMT), Coronary Artery Calcification Score (CACS), serum mineral parameters, lipids, as well asthe calcification modulators: matrix Gla protein (MGP), desphosphorylated-uncarboxylated-MGP (dp-ucMGP), osteoprotegerin (OPG), fetuin A, osteocalcin (OC) and fibroblast grown factor 23 (FGF-23).  Results The increase of CCA-IMT was significantly lower in the K+D group (from 0.95±0.2 mm to 1.01±0.3, P=0.003) than in the D group (from 1.02±0.2 mm to 1.16±0.3, P=0.003), resulting in a ΔCCA-IMT 0.06±0.08 vs 0.136±0.05 mm, P=0.005 respectively. The increase in CACS was numerically less in K+D patients (ΔCACS: 58.1±106.5 vs 74.4±127.1 Agatson units, P=0.7). The level of dp-ucMGP and total OC decreased in K+D patients during the study, OPG increased in both groups.  Conclusions A 270-day course of 90 μg vitamin K2 administration may reduced the progression of atherosclerosis. Vitamin K2 significantly changed the pattern of promoters and calcification inhibitors dp-ucMGP, OC andOPG but failed to affect the progression of coronary artery calcification in CKD patients over the treatment period.

Study Type : Human Study

Print Options

Key Research Topics

Sayer Ji
Founder of

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022, Journal Articles copyright of original owners, MeSH copyright NLM.